BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuo CL, Shiao AS, Yung M, Sakagami M, Sudhoff H, Wang CH, Hsu CH, Lien CF. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015;2015:854024. [PMID: 25866816 DOI: 10.1155/2015/854024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Vakalapudi S, Majumdar S, Uppala D. Cholesteatoma of Maxillary Sinus Simulating Neoplasia: A Rare Case Report. Int J Appl Basic Med Res 2021;11:56-9. [PMID: 33842300 DOI: 10.4103/ijabmr.IJABMR_374_20] [Reference Citation Analysis]
2 Bächinger D, Rrahmani A, Weiss NM, Mlynski R, Huber A, Röösli C. Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system. Eur Arch Otorhinolaryngol 2021;278:1365-71. [PMID: 32661718 DOI: 10.1007/s00405-020-06208-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Solanki B, Sharma S. Cholesteatoma Versus Granulations: Changing Incidence Trends and Association with Age and Complications. Indian J Otolaryngol Head Neck Surg 2020;72:208-13. [PMID: 32551279 DOI: 10.1007/s12070-019-01765-0] [Reference Citation Analysis]
4 Nagel J, Wöllner S, Schürmann M, Brotzmann V, Müller J, Greiner JF, Goon P, Kaltschmidt B, Kaltschmidt C, Sudhoff H. Stem cells in middle ear cholesteatoma contribute to its pathogenesis. Sci Rep 2018;8:6204. [PMID: 29670222 DOI: 10.1038/s41598-018-24616-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Haghjoo S, Mousavi SH, Farsi Y, Nasery AAM, Negin F, Qaderi S. Post-surgery cholesteatoma complicated by facial nerve paralysis: A case report from Afghanistan. Int J Surg Case Rep 2021;82:105916. [PMID: 33957403 DOI: 10.1016/j.ijscr.2021.105916] [Reference Citation Analysis]
6 Fischer N, Plaikner M, Schartinger VH, Kremser C, Riechelmann H, Schmutzhard J, Gottfried T, Dejaco D, Tauber H, Josip E, Henninger B. MRI of middle ear cholesteatoma: The importance of observer reliance from diffusion sequences. J Neuroimaging 2021. [PMID: 34398501 DOI: 10.1111/jon.12919] [Reference Citation Analysis]
7 Tordrup D, Smith R, Kamenov K, Bertram MY, Green N, Chadha S. Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study. The Lancet Global Health 2022;10:e52-62. [DOI: 10.1016/s2214-109x(21)00447-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kuo CL, Shiao AS, Chen CH, Lien CF. Multidimensional staging system for pediatric acquired cholesteatoma: A 30-year verification data. Auris Nasus Larynx 2016;43:387-94. [PMID: 26443626 DOI: 10.1016/j.anl.2015.09.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Fischer N, Schartinger VH, Dejaco D, Schmutzhard J, Riechelmann H, Plaikner M, Henninger B. Readout-Segmented Echo-Planar DWI for the Detection of Cholesteatomas: Correlation with Surgical Validation. AJNR Am J Neuroradiol 2019;40:1055-9. [PMID: 31122917 DOI: 10.3174/ajnr.A6079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
10 Gao J, Tang Q, Zhu X, Wang S, Zhang Y, Liu W, Gao Z, Yang H. Long noncoding RNAs show differential expression profiles and display ceRNA potential in cholesteatoma pathogenesis. Oncol Rep 2018;39:2091-100. [PMID: 29565455 DOI: 10.3892/or.2018.6320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lipschitz N, Earl BR, Cripe TP, Samy RN. Oncolytic virotherapy: a potential therapeutic approach for cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2020;28:281-5. [PMID: 32833886 DOI: 10.1097/MOO.0000000000000651] [Reference Citation Analysis]
12 Sood N, Khandelia BK, Bugnait G. A Case Report of a Giant Cholesteatoma. J Clin Diagn Res 2017;11:ED08-10. [PMID: 28511400 DOI: 10.7860/JCDR/2017/17688.9574] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Gafford J, Freeman M, Fichera L, Noble J, Labadie R, Webster RJ 3rd. Eyes in Ears: A Miniature Steerable Digital Endoscope for Trans-Nasal Diagnosis of Middle Ear Disease. Ann Biomed Eng 2021;49:219-32. [PMID: 32458223 DOI: 10.1007/s10439-020-02518-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sarin J, Vuorenmaa M, Vallittu PK, Grénman R, Boström P, Riihilä P, Nissinen L, Kähäri VM, Pulkkinen J. The Viability and Growth of HaCaT Cells After Exposure to Bioactive Glass S53P4-Containing Cell Culture Media. Otol Neurotol 2021;42:e559-67. [PMID: 33577242 DOI: 10.1097/MAO.0000000000003057] [Reference Citation Analysis]
15 Gilarranz R, Chamizo F, Campos-herrero Navas MI, Cárdenes MÁ. Tuberculosis as a differential diagnosis in cases of persistent otorrhea refractory to standard antimicrobial treatment. Infectious Diseases 2016;49:223-4. [DOI: 10.1080/23744235.2016.1201724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Ho M. Third Window Lesions. Neuroimaging Clinics of North America 2019;29:57-92. [DOI: 10.1016/j.nic.2018.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Košec A, Matišić V, Gregurić T, Falak H, Ajduk J, Ries M. Correlation of pre-operative computed tomography, intra-operative findings and surgical outcomes in revision tympanomastoidectomy. J Laryngol Otol 2020;134:1096-102. [PMID: 33407963 DOI: 10.1017/S0022215120002698] [Reference Citation Analysis]
18 Kasai Y, Morino T, Kikuchi S, Mitsuyoshi R, Takahashi M, Yamamoto K, Yaguchi Y, Yamato M, Kojima H. Analysis of human nasal mucosal cell sheets fabricated using transported tissue and blood specimens. Regen Ther 2019;11:88-94. [PMID: 31304201 DOI: 10.1016/j.reth.2019.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Frank DN, Magno JPM, Velasco KJS, Bootpetch TC, Salud JED, David KJV, Miller AL, Yee EC, Dulnuan HP, Pyles RB, Lacuata JAC, Arbizo JL, Kofonow JM, Guce B, Mendoza KMD, Robertson CE, Ilustre GMS, Chiong ANE, Lu S, Tongol EA, Sacayan ND, Yarza TKL, Chiong CM, Santos-cortez RLP. Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media. Front Cell Infect Microbiol 2022;12:746428. [DOI: 10.3389/fcimb.2022.746428] [Reference Citation Analysis]
20 Al Tamami N, Bawazeer N, Fieux M, Zaouche S, Tringali S. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results. Am J Otolaryngol 2020;41:102542. [PMID: 32620365 DOI: 10.1016/j.amjoto.2020.102542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kuo CL, Chang NH, Shiao AS, Lien CF, Huang HL, Lin SH, Chang WP. Depression and cholesteatoma: Preliminary findings from a nationwide population-based retrospective cohort study. J Affect Disord 2016;194:222-5. [PMID: 26852187 DOI: 10.1016/j.jad.2016.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Weiss NM, Bächinger D, Rrahmani A, Bernd HE, Huber A, Mlynski R, Röösli C. Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life. Eur Arch Otorhinolaryngol 2020;277:2729-38. [PMID: 32372258 DOI: 10.1007/s00405-020-06002-x] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Nakagawa H, Toyoda Y, Albrecht T, Tsukamoto M, Praetorius M, Ishikawa T, Kamiya K, Kusunoki T, Ikeda K, Sertel S. Are human ATP-binding cassette transporter C11 and earwax associated with the incidence of cholesteatoma? Med Hypotheses 2018;114:19-22. [PMID: 29602456 DOI: 10.1016/j.mehy.2018.02.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
24 Hu Y, Qian X. Hsa_circ_0074491 regulates the malignance of cholesteatoma keratinocytes by modulating the PI3K/Akt pathway by binding to miR-22-3p and miR-125a-5p: An observational study. Medicine (Baltimore) 2021;100:e27122. [PMID: 34664835 DOI: 10.1097/MD.0000000000027122] [Reference Citation Analysis]
25 Kuo CL, Yen YC, Chang WP, Shiao AS. Association Between Middle Ear Cholesteatoma and Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg 2017;143:757-63. [PMID: 28494066 DOI: 10.1001/jamaoto.2017.0130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
26 Król B, Cywka KB, Skarżyńska MB, Skarżyński PH. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results. Am J Otolaryngol 2021;42:102895. [PMID: 33429176 DOI: 10.1016/j.amjoto.2020.102895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Król B, Porowski M, Cywka KB, Skarżyńska MB, Skarżyński PH. Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report. Am J Case Rep 2020;21:e925914. [PMID: 33168798 DOI: 10.12659/AJCR.925914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Castle JT. Cholesteatoma Pearls: Practical Points and Update. Head Neck Pathol 2018;12:419-29. [PMID: 30069838 DOI: 10.1007/s12105-018-0915-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
29 Yeşilova M, Görür K, Ismi O, Özcan C, Büyükafşar K. The Role of Rho/Rho-Kinase Pathway in the Pathogenesis of Cholesteatoma. Otol Neurotol 2017;38:516-20. [PMID: 28288476 DOI: 10.1097/MAO.0000000000001344] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Kan T, Ueda H, Takahara T, Tsuchiya Y, Kishimoto M, Uchida Y, Ogawa T, Ohashi W, Tsuzuki T, Fujimoto Y. Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma. Biomed Res Int 2021;2021:6644897. [PMID: 33778077 DOI: 10.1155/2021/6644897] [Reference Citation Analysis]
31 Ten Tije FA, Merkus P, Buwalda J, Blom HM, Kramer SE, Pauw RJ; DCD Consortium. Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care. Eur Arch Otorhinolaryngol 2021;278:3777-87. [PMID: 33336300 DOI: 10.1007/s00405-020-06478-7] [Reference Citation Analysis]
32 Imai R, Sato T, Iwamoto Y, Hanada Y, Terao M, Ohta Y, Osaki Y, Imai T, Morihana T, Okazaki S, Oshima K, Okuzaki D, Katayama I, Inohara H. Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling. J Assoc Res Otolaryngol 2019;20:449-59. [PMID: 31254133 DOI: 10.1007/s10162-019-00727-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Hussain Z, Pei R. Necessities, opportunities, and challenges for tympanic membrane perforation scaffolding-based bioengineering. Biomed Mater 2020. [PMID: 33260166 DOI: 10.1088/1748-605X/abcf5d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Jovanovic I, Zivkovic M, Djuric T, Stojkovic L, Jesic S, Stankovic A. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature. Laryngoscope 2020;130:E220-7. [PMID: 31132150 DOI: 10.1002/lary.28084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Orji FT, Ukaegbe O, Alex-Okoro J, Ofoegbu VC, Okorafor IJ. The changing epidemiological and complications profile of chronic suppurative otitis media in a developing country after two decades. Eur Arch Otorhinolaryngol 2016;273:2461-6. [PMID: 26611685 DOI: 10.1007/s00405-015-3840-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Frumm SM, Yu SK, Chang J, Artichoker JA, Scaria SM, Lee KP, Byrnes LE, Sneddon JB, Tward AD. A Hierarchy of Proliferative and Migratory Keratinocytes Maintains the Tympanic Membrane. Cell Stem Cell 2021;28:315-330.e5. [PMID: 33181078 DOI: 10.1016/j.stem.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Barry JY, Reghunathan S, Jacob A. Tympanosclerosis Presenting as Mass: Workup and Differential. Case Rep Otolaryngol 2016;2016:9821493. [PMID: 27656306 DOI: 10.1155/2016/9821493] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Laske RD, Roth TN, Baráth K, Schuknecht B, Huber AM, Röösli C. The Role of Non-Echoplanar Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Primary Cholesteatoma and Cholesteatoma Recidivism as an Adjunct to Clinical Evaluation. Ann Otol Rhinol Laryngol 2018;127:919-25. [DOI: 10.1177/0003489418800833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Campion T, Taranath A, Pinelli L, Ugga L, Nash R, Talenti G, Dahmoush H, D’arco F. Imaging of temporal bone inflammations in children: a pictorial review. Neuroradiology 2019;61:959-70. [DOI: 10.1007/s00234-019-02258-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Casazza G, Carlson ML, Shelton C, Gurgel RK. The Medially-Invasive Cholesteatoma: An Aggressive Subtype of a Common Pathology. Ann Otol Rhinol Laryngol 2021;130:38-46. [PMID: 32602346 DOI: 10.1177/0003489420937731] [Reference Citation Analysis]
41 Miyake S, Miwa T, Yoneda G, Kanemaru A, Saito H, Minoda R, Orita Y, Saito H, Jono H. Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma. PLoS One 2020;15:e0240216. [PMID: 33031450 DOI: 10.1371/journal.pone.0240216] [Reference Citation Analysis]
42 Alexander A, Mahoney P, Scurrell E, Baines S. Cholesteatoma in a cat. JFMS Open Rep 2019;5:2055116919848086. [PMID: 31205737 DOI: 10.1177/2055116919848086] [Reference Citation Analysis]
43 Mishra AK, Mallick A, Galagali JR, Gupta A, Sethi A, Ghotra A. Mastoid cavity obliteration using bone pâté versus bioactive glass granules in the management of chronic otitis media (squamous disease): a prospective comparative study. J Laryngol Otol 2021;135:492-500. [PMID: 33975661 DOI: 10.1017/S0022215121001195] [Reference Citation Analysis]
44 Piersiala K, Klimza H, Jackowska J, Wierzbicka M. Parotid gland cholesteatoma in a 23-year-old male: Case report. SAGE Open Med Case Rep 2017;5:2050313X17749083. [PMID: 29318020 DOI: 10.1177/2050313X17749083] [Reference Citation Analysis]
45 de Veij Mestdagh PD, Colnot DR, Borggreven PA, Orelio CC, Quak JJ. Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery. Acta Otolaryngol 2017;137:690-4. [PMID: 28125327 DOI: 10.1080/00016489.2017.1279346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
46 Basonbul RA, Ronner EA, Kozin ED, Lee DJ, Cohen MS. Systematic Review of Endoscopic Ear Surgery Outcomes for Pediatric Cholesteatoma. Otology & Neurotology 2021;42:108-15. [DOI: 10.1097/mao.0000000000002876] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Choffor-Nchinda E, Djomou F, Meva'a Biouele RC, Mindja D, Bola A, Kewe I, Vokwely JE, Njock R. Determinants of hearing loss severity in tympanic membrane perforations in a sub-Saharan African setting. J Laryngol Otol 2018;132:1013-7. [PMID: 30409241 DOI: 10.1017/S0022215118001962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Vestby LK, Grønseth T, Simm R, Nesse LL. Bacterial Biofilm and its Role in the Pathogenesis of Disease. Antibiotics (Basel) 2020;9:E59. [PMID: 32028684 DOI: 10.3390/antibiotics9020059] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 40.5] [Reference Citation Analysis]
49 Pairaudeau C, Mendonca C. Anaesthesia for major middle ear surgery. BJA Educ 2019;19:136-43. [PMID: 33456882 DOI: 10.1016/j.bjae.2019.01.006] [Reference Citation Analysis]
50 Eggink MC, de Wolf MJF, Ebbens FA, Dikkers FG, van Spronsen E. Evaluation of Long-term Cholesteatoma Recidivism: Using the JOS, EAONO-JOS, and STAMCO Cholesteatoma Staging Systems. Otol Neurotol 2021;42:1031-8. [PMID: 34260507 DOI: 10.1097/MAO.0000000000003150] [Reference Citation Analysis]
51 Im GJ, do Han K, Park KH, Cho CH, Jang H, Lee JH, Lee SH. Rate of chronic otitis media operations and cholesteatoma surgeries in South Korea: a nationwide population-based study (2006-2018). Sci Rep 2020;10:11356. [PMID: 32647201 DOI: 10.1038/s41598-020-67799-5] [Reference Citation Analysis]
52 Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y, Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin Exp Otorhinolaryngol 2016;9:298-308. [PMID: 27440129 DOI: 10.21053/ceo.2015.01662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
53 Bhalla AS, Singh A, Jana M. Chronically Discharging Ears: Evalution with High Resolution Computed Tomography. Pol J Radiol 2017;82:478-89. [PMID: 29662576 DOI: 10.12659/PJR.901936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Leichtle A, Leffers D, Daerr MG, Draf C, Kurabi A, Ryan AF, Rupp J, Bruchhage KL. [Immunomodulation in Cholesteatoma]. Laryngorhinootologie 2021. [PMID: 34233375 DOI: 10.1055/a-1516-4447] [Reference Citation Analysis]
55 Thompson LD. Update From the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear. Head Neck Pathol 2017;11:78-87. [PMID: 28247225 DOI: 10.1007/s12105-017-0790-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
56 Hajare P, Mathew RS, Singh A, Shetty SS. Intraoperative Classification of Cholesteatoma Using ChOLE Classification and Evaluating its Treatment Outcomes Using Inside Out Approach Mastoidectomy. Indian J Otolaryngol Head Neck Surg 2021;73:437-42. [PMID: 34692455 DOI: 10.1007/s12070-020-02055-w] [Reference Citation Analysis]
57 Kuo CL. In reference to A new theory on the pathogenesis of acquired cholesteatoma: mucosal traction. Laryngoscope 2016;126:E132. [PMID: 26421908 DOI: 10.1002/lary.25701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Kuo CL, Shiao AS, Wen HC, Chang WP. Increased risk of cholesteatoma among patients with allergic rhinitis: A nationwide investigation. Laryngoscope 2018;128:547-53. [PMID: 28771810 DOI: 10.1002/lary.26220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
59 Palkó E, Póliska S, Sziklai I, Penyige A. Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma. PLoS One 2018;13:e0200840. [PMID: 30021014 DOI: 10.1371/journal.pone.0200840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Spinner A, Munjuluru A, Wootten CT. Prevalence of Cholesteatoma in Children With Down Syndrome Receiving Treatment at Pediatric Health Care Facilities. JAMA Otolaryngol Head Neck Surg 2020;146:864-5. [PMID: 32729894 DOI: 10.1001/jamaoto.2020.1854] [Reference Citation Analysis]
61 Kurabi A, Cooper M, Spriggs M, Xu Y, Schaerer D, Ryan AF. Molecular Screening Strategy to Identify a Non-invasive Delivery Mechanism for the Treatment of Middle Ear Disorders. Front Med (Lausanne) 2020;7:503819. [PMID: 33392211 DOI: 10.3389/fmed.2020.503819] [Reference Citation Analysis]
62 Wang X, Guo J, Liu W, Chen M, Shao J, Zhang X, Ma N, Li Y, Peng Y, Zhang J. Comparison of the EAONO/JOS, STAMCO and ChOLE cholesteatoma staging systems in the prognostic evaluation of acquired middle ear cholesteatoma in children. Eur Arch Otorhinolaryngol 2022. [PMID: 35554663 DOI: 10.1007/s00405-022-07400-z] [Reference Citation Analysis]
63 George M, Alexander A, Mathew J, Iyer A, Waterval J, Simon C, Marchioni D, Maire R. Proposal of a timing strategy for cholesteatoma surgery during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2020;277:2619-23. [PMID: 32415348 DOI: 10.1007/s00405-020-06037-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Lee JA, Fuller SR, Nguyen SA, Meyer TA. Factors affecting complications and comorbidities in children with cholesteatoma. Int J Pediatr Otorhinolaryngol 2020;135:110080. [PMID: 32413646 DOI: 10.1016/j.ijporl.2020.110080] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Russo C, Elefante A, Cavaliere M, Di Lullo AM, Motta G, Iengo M, Brunetti A. Apparent diffusion coefficients for predicting primary cholesteatoma risk of recurrence after surgical clearance. Eur J Radiol 2020;125:108915. [PMID: 32114332 DOI: 10.1016/j.ejrad.2020.108915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Król B, Cywka KB, Skarżyńska MB, Skarżyński PH. Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results. Life (Basel) 2021;11:374. [PMID: 33921929 DOI: 10.3390/life11050374] [Reference Citation Analysis]
67 Chen CK, Chang KP, Chien CY, Hsieh LC. Endoscopic transcanal removal of external auditory canal osteomas. Biomed J 2020:S2319-4170(20)30039-1. [PMID: 32330680 DOI: 10.1016/j.bj.2020.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Shih CP, Lee JT, Chen HK, Lin YC, Chen HC, Lin YY, Kuo CY, Chen YT, Wang CH. Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia. Sci Rep 2018;8:125. [PMID: 29317713 DOI: 10.1038/s41598-017-18536-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]